Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.
Journal: Expert opinion on biological therapy
Published: August 29, 2026
BPI26-030: Real-World Adherence to NCCN-Guideline-Recommended Peri-Operative Systemic Therapy in Muscle-Invasive Urothelial Carcinoma: An NCDB Analysis (2018-2021).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 01, 2026
CRE26-058: Cholestatic Jaundice From Hepatic Extramedullary Hematopoiesis in Metastatic Prostate Adenocarcinoma With Diffuse Marrow Infiltration.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study).
Journal: ESMO open
Published: April 21, 2026
Sertoli cell tumor in familial adenomatous polyposis: a case report.
Journal: Frontiers in oncology
Published: April 15, 2026
CRE26-058: Cholestatic Jaundice From Hepatic Extramedullary Hematopoiesis in Metastatic Prostate Adenocarcinoma With Diffuse Marrow Infiltration.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 31, 2026
BPI26-030: Real-World Adherence to NCCN-Guideline-Recommended Peri-Operative Systemic Therapy in Muscle-Invasive Urothelial Carcinoma: An NCDB Analysis (2018-2021).
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis.
Journal: Cancers
Published: March 28, 2026
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
Journal: European urology open science
Published: March 12, 2026
Survival Outcomes of First-Line Therapy in De Novo Metastatic Urothelial Carcinoma with Histologic Subtypes: A National Cancer Database Analysis.
Journal: Cancers
Published: February 05, 2026
Case Report: Gangrene after one dose of investigational stannic pentetate radiopharmaceutical.
Journal: Frontiers in oncology
Published: January 29, 2026
Lineage infidelity in FH-deficient RCC with secondary somatic alterations: a case report and implications for diagnosis and treatment.
Journal: Therapeutic advances in medical oncology
Published: December 11, 2025
Last Updated: 09/26/2026